Compare Charles River Laboratories Intl. Inc (CRL) vs LTC Properties Inc (LTC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs LTC Properties Inc — how do they compare? Charles River Laboratories Intl. Inc trades at $302.01 (market cap $14.23B), while LTC Properties Inc trades at $43.29 (market cap $2.27B). The key difference: Charles River Laboratories Intl. Inc is far larger — about 6.3× LTC Properties Inc's market cap, and LTC Properties Inc pays a 5.42% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Charles River Laboratories Intl. Inc for 33 Days and LTC Properties Inc for 89 Days on average.
| CRL | LTC | |
|---|---|---|
Market Cap | $14.23B | $2.27B |
Volume | 1,176,885 | 574,171 |
Sector | Health | Real Estate |
52-Week High | $310.77 | $43.50 |
52-Week Low | $149.93 | $33.98 |
Typical Hold Time | 33 Days | 89 Days |
Enterprise Value | $17.06B | $3.01B |
Dividend Yield | — | 5.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $300.53, up 0.08% on the day, with a bullish technical outlook and strong analyst support. The stock has consistently beaten earnings estimates in recent quarters, though it faces profitability challenges with a negative net income margin and ROE. Recent investor day presentations highlighted a strategic plan targeting 5-7% revenue growth and $300 million in savings by 2030, driving positive sentiment.
The outlook is cautiously optimistic, supported by analyst buy ratings and a $305.50 consensus price target, but risks include ongoing margin pressure, volatile non-human primate costs, and a high valuation multiple. Earnings growth and successful execution of the new strategic plan are critical for sustained upside.
LTC Properties trades at $41.81, down 1.48% over the past day. The stock shows a mixed technical picture with a bullish moving average signal but neutral oscillators. Fundamentally, the company reported strong revenue growth to $262.85 million in 2025 and a net income margin of 38.93%, though earnings have been volatile with a recent miss in Q1 2026. Recent corporate actions include ongoing monthly dividends of $0.19 per share and strategic acquisitions to accelerate growth in seniors housing properties.
The outlook for LTC is cautiously optimistic, supported by demographic tailwinds in senior care and a consensus price target of $49.67 implying 19% upside. Key risks include rising interest rates impacting financing costs and execution challenges in transitioning its portfolio. Analyst sentiment is mixed with 32% buy ratings, highlighting balanced risk-reward near current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About LTC Properties Inc
LTC Properties Inc is a healthcare facility real estate investment trust. The company operates one segment that works to invest in healthcare facilities through mortgage loans, property lease transactions, and other investments. LTC generates all of its revenue in the United States. LTC is an active capital provider in the seniors housing and health care real estate industry. The company has been actively engaged with its operating partners to create a growing pipeline of projects. LTC considers merger and acquisition investment as a component of its operational growth strategy.
Read more on LTC →
